{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T19:18:36Z","timestamp":1775330316937,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s10620-024-08499-2","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T18:02:10Z","timestamp":1720634530000},"page":"3554-3562","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Burden of Portal Hypertension Complications Is Greater in Liver Transplant Wait-Listed Registrants with End-Stage Liver Disease and Type 2 Diabetes"],"prefix":"10.1007","volume":"69","author":[{"given":"Idris","family":"Yakubu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiba","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madison","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rehan","family":"Razzaq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vaishali","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinay","family":"Kumaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Shadab","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,10]]},"reference":[{"key":"8499_CR1","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1002\/hep.31806","volume":"74","author":"AS Alexopoulos","year":"2021","unstructured":"Alexopoulos AS, Crowley MJ, Wang Y et al. Glycemic Control Predicts Severity of Hepatocyte Ballooning and Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease. Hepatology 2021;74:1220\u20131233.","journal-title":"Hepatology"},{"key":"8499_CR2","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1002\/hep.28783","volume":"64","author":"S McPherson","year":"2016","unstructured":"McPherson S, Anstee QM. Changing epidemiology of chronic liver disease among ethnic groups in the United States. Hepatology 2016;64:1843\u20131846.","journal-title":"Hepatology"},{"key":"8499_CR3","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1007\/s10620-015-3627-7","volume":"60","author":"MS Siddiqui","year":"2015","unstructured":"Siddiqui MS, Cheang KL, Luketic VA et al. Nonalcoholic Steatohepatitis (NASH) Is Associated with a Decline in Pancreatic Beta Cell (beta-Cell) Function. Dig Dis Sci 2015;60:2529\u20132537. https:\/\/doi.org\/10.1007\/s10620-015-3627-7.","journal-title":"Dig Dis Sci"},{"key":"8499_CR4","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","volume":"149","author":"P Angulo","year":"2015","unstructured":"Angulo P, Kleiner DE, Dam-Larsen S et al. Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology 2015;149:389\u201397 e10.","journal-title":"Gastroenterology"},{"key":"8499_CR5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S1665-2681(19)31588-1","volume":"10","author":"JO Quintana","year":"2011","unstructured":"Quintana JO, Garcia-Compean D, Gonzalez JA et al. The impact of diabetes mellitus in mortality of patients with compensated liver cirrhosis-a prospective study. Annals of hepatology 2011;10:56\u201362.","journal-title":"Annals of hepatology"},{"key":"8499_CR6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/j.1572-0241.2005.00307.x","volume":"101","author":"T Nishida","year":"2006","unstructured":"Nishida T, Tsuji S, Tsujii M et al. Oral glucose tolerance test predicts prognosis of patients with liver cirrhosis. Am J Gastroenterol 2006;101:70\u201375.","journal-title":"Am J Gastroenterol"},{"key":"8499_CR7","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.cgh.2010.10.035","volume":"9","author":"K Berman","year":"2011","unstructured":"Berman K, Tandra S, Forssell K et al. Incidence and predictors of 30-day readmission among patients hospitalized for advanced liver disease. Clinical gastroenterology and hepatology\u202f: the official clinical practice journal of the American Gastroenterological Association 2011;9:254\u2013259.","journal-title":"Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association"},{"key":"8499_CR8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1056\/NEJMp068177","volume":"356","author":"P Hossain","year":"2007","unstructured":"Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world\u2013a growing challenge. N Engl J Med 2007;356:213\u2013215.","journal-title":"N Engl J Med"},{"key":"8499_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/hep.29466","volume":"67","author":"C Estes","year":"2018","unstructured":"Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology 2018;67:123\u2013133.","journal-title":"Hepatology"},{"key":"8499_CR10","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/hep.27228","volume":"60","author":"L Elkrief","year":"2014","unstructured":"Elkrief L, Chouinard P, Bendersky N et al. Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis C. Hepatology 2014;60:823\u2013831.","journal-title":"Hepatology"},{"key":"8499_CR11","first-page":"119","volume":"20","author":"G Bianchi","year":"1994","unstructured":"Bianchi G, Marchesini G, Zoli M, Bugianesi E, Fabbri A, Pisi E. Prognostic significance of diabetes in patients with cirrhosis. Hepatology 1994;20:119\u2013125.","journal-title":"Hepatology"},{"key":"8499_CR12","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1002\/hep.21176","volume":"43","author":"A Sangiovanni","year":"2006","unstructured":"Sangiovanni A, Prati GM, Fasani P et al. The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients. Hepatology 2006;43:1303\u20131310.","journal-title":"Hepatology"},{"key":"8499_CR13","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/j.1478-3231.2004.0991.x","volume":"24","author":"R Moreau","year":"2004","unstructured":"Moreau R, Delegue P, Pessione F et al. Clinical characteristics and outcome of patients with cirrhosis and refractory ascites. Liver international: official journal of the International Association for the Study of the Liver 2004;24:457\u2013464.","journal-title":"Liver international: official journal of the International Association for the Study of the Liver"},{"key":"8499_CR14","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","volume":"44","author":"G D'Amico","year":"2006","unstructured":"D\u2019Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. Journal of hepatology 2006;44:217\u2013231.","journal-title":"Journal of hepatology"},{"key":"8499_CR15","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1111\/liv.14092","volume":"39","author":"SS Patel","year":"2019","unstructured":"Patel SS, Lin FP, Rodriguez VA et al. The relationship between coronary artery disease and cardiovascular events early after liver transplantation. Liver international\u202f: official journal of the International Association for the Study of the Liver 2019;39:1363\u20131371.","journal-title":"Liver international : official journal of the International Association for the Study of the Liver"},{"key":"8499_CR16","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/lt.25067","volume":"24","author":"SS Patel","year":"2018","unstructured":"Patel SS, Guzman LA, Lin FP et al. Utilization of aspirin and statin in management of coronary artery disease in patients with cirrhosis undergoing liver transplant evaluation. Liver Transpl 2018;24:872\u2013880.","journal-title":"Liver Transpl"},{"key":"8499_CR17","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/lt.25012","volume":"24","author":"SS Patel","year":"2018","unstructured":"Patel SS, Nabi E, Guzman L et al. Coronary artery disease in decompensated patients undergoing liver transplantation evaluation. Liver Transpl 2018;24:333\u2013342.","journal-title":"Liver Transpl"},{"key":"8499_CR18","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/hep.28906","volume":"65","author":"G Garcia-Tsao","year":"2017","unstructured":"Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology 2017;65:310\u2013335.","journal-title":"Hepatology"},{"key":"8499_CR19","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1080\/17474124.2020.1791704","volume":"14","author":"M Finotti","year":"2020","unstructured":"Finotti M, Vitale A, Volk M, Cillo U. A 2020 update on liver transplant for hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol 2020;14:885\u2013900.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"8499_CR20","first-page":"S5","volume":"24","author":"A Cannon","year":"2018","unstructured":"Cannon A, Handelsman Y, Heile M, Shannon M. Burden of Illness in Type 2 Diabetes Mellitus. J Manag Care Spec Pharm 2018;24:S5\u2013S13.","journal-title":"J Manag Care Spec Pharm"},{"key":"8499_CR21","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S1542-3565(04)00014-X","volume":"2","author":"ZM Younossi","year":"2004","unstructured":"Younossi ZM, Gramlich T, Matteoni CA, Boparai N, McCullough AJ. Nonalcoholic fatty liver disease in patients with type 2 diabetes. Clinical gastroenterology and hepatology\u202f: the official clinical practice journal of the American Gastroenterological Association 2004;2:262\u2013265.","journal-title":"Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association"},{"key":"8499_CR22","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1111\/j.1572-0241.2006.00649.x","volume":"101","author":"SH Sigal","year":"2006","unstructured":"Sigal SH, Stanca CM, Kontorinis N, Bodian C, Ryan E. Diabetes mellitus is associated with hepatic encephalopathy in patients with HCV cirrhosis. Am J Gastroenterol 2006;101:1490\u20131496.","journal-title":"Am J Gastroenterol"},{"key":"8499_CR23","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1111\/j.1478-3231.2007.01562.x","volume":"27","author":"E Kalaitzakis","year":"2007","unstructured":"Kalaitzakis E, Olsson R, Henfridsson P et al. Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis. Liver international\u202f: official journal of the International Association for the Study of the Liver 2007;27:1194\u20131201.","journal-title":"Liver international : official journal of the International Association for the Study of the Liver"},{"key":"8499_CR24","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1056\/NEJMoa1008862","volume":"364","author":"S Rao Kondapally Seshasai","year":"2011","unstructured":"Rao Kondapally Seshasai S, Kaptoge S, Thompson A et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 2011;364:829\u2013841.","journal-title":"N Engl J Med"},{"key":"8499_CR25","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1007\/s10620-013-2802-y","volume":"58","author":"HK Jeon","year":"2013","unstructured":"Jeon HK, Kim MY, Baik SK et al. Hepatogenous diabetes in cirrhosis is related to portal pressure and variceal hemorrhage. Dig Dis Sci 2013;58:3335\u20133341. https:\/\/doi.org\/10.1007\/s10620-013-2802-y.","journal-title":"Dig Dis Sci"},{"key":"8499_CR26","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1007\/s10620-016-4261-8","volume":"61","author":"TL Liu","year":"2016","unstructured":"Liu TL, Trogdon J, Weinberger M, Fried B, Barritt AS. Diabetes Is Associated with Clinical Decompensation Events in Patients with Cirrhosis. Dig Dis Sci 2016;61:3335\u20133345. https:\/\/doi.org\/10.1007\/s10620-016-4261-8.","journal-title":"Dig Dis Sci"},{"key":"8499_CR27","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.jhep.2012.04.028","volume":"57","author":"Y Calmus","year":"2012","unstructured":"Calmus Y, Conti F, Cluzel P et al. Prospective assessment of renal histopathological lesions in patients with end-stage liver disease: effects on long-term renal function after liver transplantation. Journal of hepatology 2012;57:572\u2013576.","journal-title":"Journal of hepatology"},{"key":"8499_CR28","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/BF02900711","volume":"20","author":"T Trenti","year":"1990","unstructured":"Trenti T, Cristani A, Cioni G, Pentore R, Mussini C, Ventura E. Fructosamine and glycated hemoglobin as indices of glycemic control in patients with liver cirrhosis. Ric Clin Lab 1990;20:261\u2013267.","journal-title":"Ric Clin Lab"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08499-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-024-08499-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08499-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T20:30:40Z","timestamp":1726864240000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-024-08499-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,10]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["8499"],"URL":"https:\/\/doi.org\/10.1007\/s10620-024-08499-2","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,10]]},"assertion":[{"value":"23 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors of this manuscript have conflicts of interest to disclose as described by the American Journal of Transplantation. MSS: AMRA, NovoNordisk. IY: Takeda Pharmaceuticals (Consultant). None: SF, TA, VP, VK, AS.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}